Venus Remedies Limited (VENUSREM) — FY26 Annual Report | 24 July 2026

Venus Remedies Limited announced its 37th AGM on August 20, 2026, via video conferencing, with resolutions including adoption of new Articles of Association, capital clause amendment, director reappointments, and special resolutions for new director appointments and auditor remuneration. The filing details shareholder voting procedures, e-voting timelines, dividend eligibility (₹10 per share, record date August 7, 2026), and mandatory dematerialization requirements. Key disclosures include director appointments (Dr. Gurminder Singh Bedi as Whole-time Director, Dr. Manu Chaudhary reappointed for five years), remuneration details, and compliance with SEBI and MCA regulations. The company emphasized its debt-free status, global operations across 100+ countries, and strategic focus on R&D, digital transformation, and sustainable growth through initiatives like Venus Industrial Park by 2030.